Latest Takeda Pharmaceutical Company Stories
Expresses Continued Confidence in ACTOS DEERFIELD, Ill., Oct. 3, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc.
Case Funding Firm adds to funding amounts as Bellwether trials kick into high gear after $9Bil verdict is failed to be dismissed on Takeda post-trial motion. HOUSTON, Sept.
Actos Lawsuit Help Center Website reports that Takeda and Eli Lilly loses bid to have Judge throw out recent $9Bil Jury verdict. NEW ORLEANS, Sept.
Primary Research Provides Key Insights and Tools for Health Care Professionals DEERFIELD, Ill. and ALEXANDRIA, Va., Sept.
Drug makers Takeda and Eli Lilly lost a bid to have the Actos trial thrown out.
Takeda Stresses Continued Confidence in ACTOS DEERFIELD, Ill. and OSAKA, Japan, Sept.
The Firm is evaluating Actos lawsuits on behalf of individuals who developed bladder cancer, allegedly due to long-term use of the Type 2 diabetes drug. New
In light of the latest development in Actos litigation, The Law Office of Melinda J. Helbock A.P.C.
MT Services LLC informs plaintiffs on ongoing cases with Takeda Pharmaceutical, manufacturer of Actos (Pioglitazone hydrochloride) diabetes drug, seeking post-trial motions to lower $9Bil.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.